Clovis Oncology

IPO

Public · Boulder, United States · Founded 2009 · $145.0M raised

Headquarters
Boulder, Colorado
Employees
201–500
Founded
2009
Business Model
B2B
Total Funding
$145.0M
Last Round
$145.0M Series AMay 2009
Rounds
1
Type
Public

About

Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe, and other international markets. The company's approach to precision medicine aims to deliver the right drug to the right patient at the right time, targeting specific subsets of cancer. Clovis develops diagnostic tools in collaboration with partners to direct compounds to patients most likely to benefit.

Summary

Clovis Oncology is a Biotech company based in Boulder, United States, founded in 2009. It has raised $145.0M in total across 1 round, most recently a $145.0M Series A round in May 2009. Investors include Versant Ventures, Domain Associates and Aberdare Ventures.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPONov 2011
$130.0M

Sign up to see all 2 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clovis Oncology on Indexed.vc
<a href="https://indexed.vc/companies/clovis-oncology"><img src="https://indexed.vc/api/badge/company/clovis-oncology" alt="Clovis Oncology on Indexed.vc" width="260" height="76" /></a>